Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Catalent, Inc. | Director | Common Stock | 32.7K | $1.96M | $59.97 | Oct 30, 2024 | Direct |
TherapeuticsMD, Inc. | Director | Common Stock | 107K | $239K | $2.24 | Aug 10, 2021 | Direct |
Esperion Therapeutics, Inc. | Director | Common Stock | 64.7K | $161K | $2.48 | May 23, 2024 | Direct |
Esperion Therapeutics, Inc. | Director | Stock Option (right to buy) | 32.5K | May 23, 2024 | Direct | ||
TherapeuticsMD, Inc. | Director | Restricted Stock Units | 0 | $3.64 | Aug 10, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTLT | Catalent, Inc. | Oct 30, 2024 | 1 | $0 | 4 | Nov 1, 2024 | Director |
ESPR | Esperion Therapeutics, Inc. | May 23, 2024 | 2 | $0 | 4 | May 24, 2024 | Director |
CTLT | Catalent, Inc. | Oct 27, 2023 | 1 | $0 | 4 | Oct 31, 2023 | Director |
CTLT | Catalent, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Director |
ESPR | Esperion Therapeutics, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
ESPR | Esperion Therapeutics, Inc. | May 10, 2023 | 2 | $48.8K | 4 | May 11, 2023 | Director |
CTLT | Catalent, Inc. | Oct 27, 2022 | 1 | $0 | 4 | Oct 31, 2022 | Director |
MNKPF | Mallinckrodt plc | Jun 16, 2022 | 0 | $0 | 4 | Jun 21, 2022 | Director |
ESPR | Esperion Therapeutics, Inc. | Jun 2, 2022 | 1 | $28.2K | 4 | Jun 3, 2022 | Director |
ESPR | Esperion Therapeutics, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 1, 2022 | Director |
ESPR | Esperion Therapeutics, Inc. | Jun 1, 2022 | 0 | $0 | 3 | Jun 1, 2022 | Director |
CTLT | Catalent, Inc. | Nov 29, 2021 | 4 | $0 | 4 | Dec 1, 2021 | Director |
CTLT | Catalent, Inc. | Oct 28, 2021 | 1 | $0 | 4 | Nov 1, 2021 | Director |
TXMD | TherapeuticsMD, Inc. | Aug 10, 2021 | 2 | $0 | 4 | Aug 12, 2021 | Director |
TXMD | TherapeuticsMD, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |